FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news